文献库搜索 | GeneLibs

Grandi(G),Piombino(C),Sighinolfi(G),Barbie... Fam Cancer 2026-05-14

...BRCA1 and 58 BRCA2 LP/PV carriers were included in the final analysis. At baseline, BRCA1 LP/PV carriers had a higher bo...

Allu(S),Saravanan(Y),Sakthivel(KM),Chinnad... Appl Biochem Biotechnol 2026-08-00

...BRCA1, BRCA2, CHEK2, ATM, HER2 and PALB2 play crucial roles in breast cancer development. The mechanism of action and th...

Kondo(S),Kida(K),Suzuki(M),Kajiura(Y),Take... Breast Cancer Res Treat 2026-05-14

...BRCA1/2 pathogenic variant carriers (BRCA+) remain controversial. This study aimed to investigate the differences in the...

De Nicolo(A),Eccles(DM),Aaltonen(K),Alhopu... J Med Genet 2026-08-26

...BRCA1 and BRCA2 specifications to the American College of Medical Genetics and Genomics/Association for Molecular Pathol...

Du(J),Duan(C),Zhang(J),Zhou(Y),Wang(Y),Zhu... Clin Breast Cancer 2026-06-00

...BRCA1: 18, BRCA2: 11), and other genes such as FANCA, PTEN. Tumors harboring comutations of TP53 and BRCA exhibited sign...

Morales-González(S),Fernández-Ramires(R),G... Hum Genomics 2026-05-14

...BRCA1 and BRCA2, followed by additional cancer susceptibility genes, with truncating variants representing the predomina...

Balar(S),Joshi(E),Rawal(R),Saiyad(H),Haque... Pathol Res Pract 2026-08-00

...BRCA1, and MYCN, whereas the HER2 3 + cohort exhibited prominent mutations in PAK1, CUL3, and TP53. Our findings establi...

Schoenen(S),Mailliez(A),Risbourg(S),Decoup... Int J Gynecol Cancer 2026-04-18

...BRCA1, BRCA2, RAD51C, RAD51D, or PALB2). Exclusion criteria include prior bilateral oophorectomy or salpingectomy and a ...

Li(X),Peng(K),Li(Q) Clin Exp Med 2026-05-17

...BRCA1/2 mutation status (OR = 1.95, 95% CI: 1.04-3.66, p = 0.037), and neutrophil-to-lymphocyte ratio (NLR) (OR = 5.61, ...

Jani(CT),Tran(E),Zhang(N),Tsai(J),Dong(J),... Clin Cancer Res 2026-05-15

...BRCA1 (4%/2.1%), and CDK12 (5.9%/5.9%). After taxane, frequent alterations included TP53 (47.2%→54%), AR (33.2%/49.9%), ...